Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2000 1
2003 1
2012 1
2016 1
2019 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20JC, 5BAuthor
Page 1
Health-related quality of life in older patients surviving ICU treatment for COVID-19: results from an international observational study of patients older than 70 years.
Soliman IW, Leaver S, Flaatten H, Fjølner J, Wernly B, Bruno RR, Artigas A, Bollen Pinto B, Schefold JC, Beil M, Sviri S, van Heerden PV, Szczeklik W, Elhadi M, Joannidis M, Oeyen S, Zafeiridis T, Wollborn J, Banzo MJA, Fuest K, Marsh B, Andersen FH, Moreno R, Boumendil A, Guidet B, Jung C, De Lange DW; COVIP-study group. Soliman IW, et al. Age Ageing. 2022 Feb 2;51(2):afab278. doi: 10.1093/ageing/afab278. Age Ageing. 2022. PMID: 35136896 Free PMC article.
HRQoL was assessed at 3 months after ICU admission with the Euro-QoL-5D-5L questionnaire. An outcome of 4 on any of Euro-QoL-5D-5L domains was considered unfavourable. ...Three months after inclusion, 1,224 patients (39.0%) were alive and the EQ-5D-5L from wa …
HRQoL was assessed at 3 months after ICU admission with the Euro-QoL-5D-5L questionnaire. An outcome of 4 on any of Euro-QoL-5D …
Synthesis and Crystallographic Characterization of a Reduced Bimetallic Yttrium ansa-Metallocene Hydride Complex, [K(crypt)][(μ-CpAn)Y(μ-H)]2 (CpAn = Me2Si[C5H3(SiMe3)-3]2), with a 3.4 Å Yttrium-Yttrium Distance.
Wedal JC, Anderson-Sanchez LM, Dumas MT, Gould CA, Beltrán-Leiva MJ, Celis-Barros C, Páez-Hernández D, Ziller JW, Long JR, Evans WJ. Wedal JC, et al. J Am Chem Soc. 2023 May 17;145(19):10730-10742. doi: 10.1021/jacs.3c01405. Epub 2023 May 3. J Am Chem Soc. 2023. PMID: 37133919
The magnetic data are best modeled with the presence of one 4f(9) Dy(III) center and one 4f(9)(5d(z)((2)))(1) Dy(II) center with no coupling between them. CASSCF calculations are consistent with magnetic measurements supporting the absence of coupling between the Dy center …
The magnetic data are best modeled with the presence of one 4f(9) Dy(III) center and one 4f(9)(5d(z)((2)))(1) Dy(II) center with no c …
Synthesis and Reduction of Bimetallic Methyl-Bridged Rare-Earth Metal Complexes, [(C5H4SiMe3)2Ln(μ-CH3)]2 (Ln = Y, Tb, Dy).
Dumas MT, Ziller JW, Evans WJ. Dumas MT, et al. ACS Omega. 2019 Jan 7;4(1):398-402. doi: 10.1021/acsomega.8b02665. eCollection 2019 Jan 31. ACS Omega. 2019. PMID: 31459337 Free PMC article.
The complexes [Cp'(2)Ln(mu-CH(3))](2), (Cp' = C(5)H(4)SiMe(3); Ln = Y, Tb, Dy) were reduced to determine if these methyl-bridged complexes would form mixed valent 4f (n) 5d(1) Ln(II)/4f (n) Ln(III) compounds or bimetallic 4f (n) 5d(1) Ln(II) compounds containing …
The complexes [Cp'(2)Ln(mu-CH(3))](2), (Cp' = C(5)H(4)SiMe(3); Ln = Y, Tb, Dy) were reduced to determine if these methyl-bridged complexes w …
V2 receptor antagonism of DDAVP-induced release of hemostasis factors in conscious dogs.
Bernat A, Hoffmann P, Dumas A, Serradeil-le Gal C, Raufaste D, Herbert JM. Bernat A, et al. J Pharmacol Exp Ther. 1997 Aug;282(2):597-602. J Pharmacol Exp Ther. 1997. PMID: 9262320
The rank order of the binding affinities of three V2 receptor antagonists was SR 121463 (a newly described selective V2 receptor antagonist) > OPC 31260 >> d(CH2)5D-Ile2,Ile4AVP. In conscious dogs, DDAVP (0.1-1 microg/kg I.V.) caused a dose-related increase (maxim …
The rank order of the binding affinities of three V2 receptor antagonists was SR 121463 (a newly described selective V2 receptor antagonist) …
The nature of chemical bonding in actinide and lanthanide ferrocyanides determined by X-ray absorption spectroscopy and density functional theory.
Dumas T, Guillaumont D, Fillaux C, Scheinost A, Moisy P, Petit S, Shuh DK, Tyliszczak T, Den Auwer C. Dumas T, et al. Phys Chem Chem Phys. 2016 Jan 28;18(4):2887-95. doi: 10.1039/c5cp05820a. Phys Chem Chem Phys. 2016. PMID: 26733312
In addition to providing a detailed description of the electronic structure of the ferrocyanide complex (K4Fe(II)(CN)6), the results strongly contribute to confirming the actinide 5f and 6d orbital oddity in comparison to lanthanide 4f and 5d....
In addition to providing a detailed description of the electronic structure of the ferrocyanide complex (K4Fe(II)(CN)6), the results strongl …
Higher toxicity with 42 Gy in 10 fractions as a total dose for 3D-conformal accelerated partial breast irradiation: results from a dose escalation phase II trial.
Bourgier C, Acevedo-Henao C, Dunant A, Rossier C, Levy A, El Nemr M, Dumas I, Delaloge S, Mathieu MC, Garbay JR, Taghian A, Marsiglia H. Bourgier C, et al. Radiat Oncol. 2012 Aug 22;7:141. doi: 10.1186/1748-717X-7-141. Radiat Oncol. 2012. PMID: 22913640 Free PMC article. Clinical Trial.
METHODS AND MATERIALS: From October 2007 to March 2010, a total of 48 pT1N0 BC patients were enrolled within this clinical trial: 17 patients at a TD of 42 Gy/10f/5d and 31 at a TD of 40 Gy/10f/5d. Median follow-up was 19 months (min-max, 12-26). ...
METHODS AND MATERIALS: From October 2007 to March 2010, a total of 48 pT1N0 BC patients were enrolled within this clinical trial: 17 patient …
[Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
Seitz JF, Milan C, Giovannini M, Dumas F, Cauvin JM, Conroy T, François E, Renard P, Votte-Lambert A, Paillot B, Bedenne L; Fondation Française de Cancérologie Digestive; Groupe Digestif de la Fédération Nationale des Centres de Lutte Contre le Cancer. Seitz JF, et al. Gastroenterol Clin Biol. 2000 Feb;24(2):201-10. Gastroenterol Clin Biol. 2000. PMID: 12687962 Clinical Trial. French.
Treatment included 3 cycles of chemotherapy by 5-FU continuous infusion (800 mg/m2.d D1-D5, D22-D26, D43-D47), cisplatin (70 mg/m2 D2, D23, D44) and radiotherapy 15 Gy/5d (D1-D5, D22-26, D43-D47). Efficacy was analyzed by endoscopy, biopsy and computerized axial tomography …
Treatment included 3 cycles of chemotherapy by 5-FU continuous infusion (800 mg/m2.d D1-D5, D22-D26, D43-D47), cisplatin (70 mg/m2 D2, D23, …